Literature DB >> 11164307

Vaccination against ovine footrot using a live bacterial vector to deliver basic protease antigen.

R J Moore1, D J Stewart, K Lund, A L Hodgson.   

Abstract

A strain of Corynebacterium pseudotuberculosis, designated Toxminus, that has been rationally attenuated by deletion of the phospholipase D gene, is being developed as a live vaccine vector for the delivery of veterinary vaccine antigens. In the present study a recombinant form of the basic protease gene of the ovine footrot causative bacterium, Dichelobacter nodosus, was introduced into the vector strain using the high copy number plasmid pEP2. This strain secreted the basic protease protein. Vaccination trials in sheep with the recombinant strain demonstrated that, although an IgG immune response was elicited, the animals were not protected from footrot following artificial challenge under pen conditions. Although the sheep were not protected there was evidence that the progression of the disease was slowed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11164307     DOI: 10.1111/j.1574-6968.2001.tb09468.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

Review 1.  Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes.

Authors:  Olivia Cano-Garrido; Joaquin Seras-Franzoso; Elena Garcia-Fruitós
Journal:  Microb Cell Fact       Date:  2015-09-16       Impact factor: 5.328

Review 2.  Development of vaccine delivery vehicles based on lactic acid bacteria.

Authors:  Shirin Tarahomjoo
Journal:  Mol Biotechnol       Date:  2012-06       Impact factor: 2.695

3.  An iron-acquisition-deficient mutant of Corynebacterium pseudotuberculosis efficiently protects mice against challenge.

Authors:  Dayana Ribeiro; Flávia de Souza Rocha; Kátia Morais Costa Leite; Siomar de Castro Soares; Artur Silva; Ricardo Wagner Dias Portela; Roberto Meyer; Anderson Miyoshi; Sérgio Costa Oliveira; Vasco Azevedo; Fernanda Alves Dorella
Journal:  Vet Res       Date:  2014-03-06       Impact factor: 3.683

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.